GPT and type 2 diabetes mellitus: Com-pared with the non-MAFLD group, patients in the MAFLD group had a significantly higher body mass index (BMI; p < 0.001), more frequently had T2DM (p < 0.001), hypertension (p < 0.001), and used statins (p = 0.008), had higher serum ALT (p = 0.001) and a higher platelet count (p < 0.001), and were more likely to have well-differentiated histologic grade (p < 0.001), but were less likely to have microvascular invasion (p < 0.001) and had lower serum AFP (p = 0.006).